Ju-Woo Nho, Debolina Banerjee, Dwight D Harris, Christopher Stone, Hang Xing, Meghamsh Kanuparthy, Janelle Li, Frank W Sellke, Jun Feng
{"title":"非糖尿病和糖尿病人冠状动脉内皮细胞模拟心梗缺血/再灌注后蛋白激酶C-β的抑制和生存信号传导","authors":"Ju-Woo Nho, Debolina Banerjee, Dwight D Harris, Christopher Stone, Hang Xing, Meghamsh Kanuparthy, Janelle Li, Frank W Sellke, Jun Feng","doi":"10.1097/XCS.0000000000001248","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Cardioplegic-ischemia/reperfusion (I/R) injury poses substantial challenges during postoperative recovery, with diabetic patients particularly susceptible to adverse events. Using a model entailing the subjection of human coronary artery endothelial cells (HCAECs) to simulated cardioplegic I/R, we investigated the potential of protein kinase C β (PKC-β) inhibition to augment cellular survival in this context.</p><p><strong>Study design: </strong>HCAECs were isolated from harvested coronary arteries of diabetic (D) and nondiabetic (C) patients (N = 4 per group). HCAECs were either cultured under normoxic conditions without drug (D and C), subjected to hypoxia and reoxygenation alone (DH and CH), or subjected to hypoxia and reoxygenation and the PKC-β inhibitor LY333531 (DHT and CHT). Molecular signaling was assessed using immunoblotting.</p><p><strong>Results: </strong>Simulated I/R decreased anti-apoptotic phosphorylated protein kinase b (p-Akt, p = 0.04) and p-Akt:Akt ratio (p = 0.004) in CH vs C, with PKC-β inhibition restoring expression in CHT (p ≤ 0.04). Treatment also increased the p-Akt:Akt ratio in DHT vs D (p = 0.03). Anti-apoptotic inducible nitric oxide synthase increased in CHT vs CH (p = 0.003), and the pro-apoptotic phosphorylated class O forkhead box transcription factor (p-FOXO): FOXO ratio decreased in CHT vs CH (p = 0.001). I/R elevated Bcl-2-associated agonist of cell death (BAD) in CH vs C (p = 0.01), but PKC-β inhibition increased anti-apoptotic p-BAD (p = 0.001) and p-BAD:BAD ratio (p = 0.03) in CHT. I/R also increased cleaved PARP (p < 0.001) and cleaved caspase 3 (p < 0.001) in DH vs D, both of which were reversed by treatment (p < 0.001 for DHT vs DH).</p><p><strong>Conclusions: </strong>PKC-β inhibitor treatment increased pro-survival signaling and decreased pro-apoptotic signaling in nondiabetic and diabetic HCAECs subjected to simulated I/R, with mechanistic differences observed between these cohorts.</p>","PeriodicalId":17140,"journal":{"name":"Journal of the American College of Surgeons","volume":" ","pages":"118-135"},"PeriodicalIF":3.8000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12147101/pdf/","citationCount":"0","resultStr":"{\"title\":\"Protein Kinase C-β Inhibition and Survival Signaling after Simulated Cardioplegic-Ischemia/Reperfusion in Nondiabetic and Diabetic Human Coronary Arterial Endothelial Cells.\",\"authors\":\"Ju-Woo Nho, Debolina Banerjee, Dwight D Harris, Christopher Stone, Hang Xing, Meghamsh Kanuparthy, Janelle Li, Frank W Sellke, Jun Feng\",\"doi\":\"10.1097/XCS.0000000000001248\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Cardioplegic-ischemia/reperfusion (I/R) injury poses substantial challenges during postoperative recovery, with diabetic patients particularly susceptible to adverse events. Using a model entailing the subjection of human coronary artery endothelial cells (HCAECs) to simulated cardioplegic I/R, we investigated the potential of protein kinase C β (PKC-β) inhibition to augment cellular survival in this context.</p><p><strong>Study design: </strong>HCAECs were isolated from harvested coronary arteries of diabetic (D) and nondiabetic (C) patients (N = 4 per group). HCAECs were either cultured under normoxic conditions without drug (D and C), subjected to hypoxia and reoxygenation alone (DH and CH), or subjected to hypoxia and reoxygenation and the PKC-β inhibitor LY333531 (DHT and CHT). Molecular signaling was assessed using immunoblotting.</p><p><strong>Results: </strong>Simulated I/R decreased anti-apoptotic phosphorylated protein kinase b (p-Akt, p = 0.04) and p-Akt:Akt ratio (p = 0.004) in CH vs C, with PKC-β inhibition restoring expression in CHT (p ≤ 0.04). Treatment also increased the p-Akt:Akt ratio in DHT vs D (p = 0.03). Anti-apoptotic inducible nitric oxide synthase increased in CHT vs CH (p = 0.003), and the pro-apoptotic phosphorylated class O forkhead box transcription factor (p-FOXO): FOXO ratio decreased in CHT vs CH (p = 0.001). I/R elevated Bcl-2-associated agonist of cell death (BAD) in CH vs C (p = 0.01), but PKC-β inhibition increased anti-apoptotic p-BAD (p = 0.001) and p-BAD:BAD ratio (p = 0.03) in CHT. I/R also increased cleaved PARP (p < 0.001) and cleaved caspase 3 (p < 0.001) in DH vs D, both of which were reversed by treatment (p < 0.001 for DHT vs DH).</p><p><strong>Conclusions: </strong>PKC-β inhibitor treatment increased pro-survival signaling and decreased pro-apoptotic signaling in nondiabetic and diabetic HCAECs subjected to simulated I/R, with mechanistic differences observed between these cohorts.</p>\",\"PeriodicalId\":17140,\"journal\":{\"name\":\"Journal of the American College of Surgeons\",\"volume\":\" \",\"pages\":\"118-135\"},\"PeriodicalIF\":3.8000,\"publicationDate\":\"2025-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12147101/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of the American College of Surgeons\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1097/XCS.0000000000001248\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/7/16 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"SURGERY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the American College of Surgeons","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/XCS.0000000000001248","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/7/16 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"SURGERY","Score":null,"Total":0}
Protein Kinase C-β Inhibition and Survival Signaling after Simulated Cardioplegic-Ischemia/Reperfusion in Nondiabetic and Diabetic Human Coronary Arterial Endothelial Cells.
Background: Cardioplegic-ischemia/reperfusion (I/R) injury poses substantial challenges during postoperative recovery, with diabetic patients particularly susceptible to adverse events. Using a model entailing the subjection of human coronary artery endothelial cells (HCAECs) to simulated cardioplegic I/R, we investigated the potential of protein kinase C β (PKC-β) inhibition to augment cellular survival in this context.
Study design: HCAECs were isolated from harvested coronary arteries of diabetic (D) and nondiabetic (C) patients (N = 4 per group). HCAECs were either cultured under normoxic conditions without drug (D and C), subjected to hypoxia and reoxygenation alone (DH and CH), or subjected to hypoxia and reoxygenation and the PKC-β inhibitor LY333531 (DHT and CHT). Molecular signaling was assessed using immunoblotting.
Results: Simulated I/R decreased anti-apoptotic phosphorylated protein kinase b (p-Akt, p = 0.04) and p-Akt:Akt ratio (p = 0.004) in CH vs C, with PKC-β inhibition restoring expression in CHT (p ≤ 0.04). Treatment also increased the p-Akt:Akt ratio in DHT vs D (p = 0.03). Anti-apoptotic inducible nitric oxide synthase increased in CHT vs CH (p = 0.003), and the pro-apoptotic phosphorylated class O forkhead box transcription factor (p-FOXO): FOXO ratio decreased in CHT vs CH (p = 0.001). I/R elevated Bcl-2-associated agonist of cell death (BAD) in CH vs C (p = 0.01), but PKC-β inhibition increased anti-apoptotic p-BAD (p = 0.001) and p-BAD:BAD ratio (p = 0.03) in CHT. I/R also increased cleaved PARP (p < 0.001) and cleaved caspase 3 (p < 0.001) in DH vs D, both of which were reversed by treatment (p < 0.001 for DHT vs DH).
Conclusions: PKC-β inhibitor treatment increased pro-survival signaling and decreased pro-apoptotic signaling in nondiabetic and diabetic HCAECs subjected to simulated I/R, with mechanistic differences observed between these cohorts.
期刊介绍:
The Journal of the American College of Surgeons (JACS) is a monthly journal publishing peer-reviewed original contributions on all aspects of surgery. These contributions include, but are not limited to, original clinical studies, review articles, and experimental investigations with clear clinical relevance. In general, case reports are not considered for publication. As the official scientific journal of the American College of Surgeons, JACS has the goal of providing its readership the highest quality rapid retrieval of information relevant to surgeons.